Attached files

file filename
EX-4.1 - FORM OF BRIDGE NOTE - Cordex Pharma, Inc.cdxp_ex41.htm
EX-10.1 - EXTENSION AND BRIDGE FUNDING AGREEMENT DATED FEBRUARY , 2010 - Cordex Pharma, Inc.cdxp_ex101.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
 
FORM 8-K
_______________
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): February 17, 2010
 
 
   CORDEX PHARMA, INC.  
   (Exact name of registrant as specified in its charter)  
 
 
Nevada
 
000-33023
 
86-0982792
(State or Other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
 
   7660 Fay Avenue, Suite H-373, La Jolla, CA 92037  
   (Address of Principal Executive Office) (Zip Code)  
 
 
   (858) 551-5700  
   (Registrant’s telephone number, including area code)  
 
 
   N/A  
   (Former name or former address, if changed since last report)  
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 



 
ITEM 8.01   OTHER EVENTS
 
     On February 17, 2010, the Company entered into an agreement with its debenture holders which, among other things, extended the maturity date of all of its outstanding debentures until March 31, 2010.  Certain debenture holders provided funding to the Company in the aggregate amount of $50,000, through loans to the Company, which loans are senior to all other secured loans other than the January 2010 loans and are on a party basis with the January 2010 loans.
 
ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.
 
 (a)  Not applicable
   
 (b)  Not applicable
   
 (c)  Not applicable 
 
Exhibit No.
 
Description
     
 
Form of Bridge Note
     
 
 Extension and Bridge Funding Agreement dated February 17, 2010

1

 
 
SIGNATURES
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
CORDEX PHARMA, INC.
 
       
Date:  February 23, 2010
By:
/s/SHEPARD GOLDBERG  
    Shepard Goldberg  
   
Chief Executive Officer
 
       
 
 
2